Logo image of OESX

ORION ENERGY SYSTEMS INC (OESX) Stock Fundamental Analysis

USA - NASDAQ:OESX - US6862751087 - Common Stock

8.9731 USD
+0.13 (+1.51%)
Last: 9/12/2025, 10:48:36 AM
Fundamental Rating

2

Overall OESX gets a fundamental rating of 2 out of 10. We evaluated OESX against 92 industry peers in the Electrical Equipment industry. Both the profitability and financial health of OESX have multiple concerns. OESX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year OESX has reported negative net income.
In the past year OESX had a positive cash flow from operations.
In multiple years OESX reported negative net income over the last 5 years.
In multiple years OESX reported negative operating cash flow during the last 5 years.
OESX Yearly Net Income VS EBIT VS OCF VS FCFOESX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

The Return On Assets of OESX (-18.95%) is comparable to the rest of the industry.
With a Return On Equity value of -85.95%, OESX perfoms like the industry average, outperforming 41.30% of the companies in the same industry.
Industry RankSector Rank
ROA -18.95%
ROE -85.95%
ROIC N/A
ROA(3y)-29.62%
ROA(5y)-10.74%
ROE(3y)-84.8%
ROE(5y)-40.02%
ROIC(3y)N/A
ROIC(5y)N/A
OESX Yearly ROA, ROE, ROICOESX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

OESX's Gross Margin of 27.88% is in line compared to the rest of the industry. OESX outperforms 57.61% of its industry peers.
In the last couple of years the Gross Margin of OESX has remained more or less at the same level.
OESX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.59%
GM growth 5Y0.98%
OESX Yearly Profit, Operating, Gross MarginsOESX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

3

2. Health

2.1 Basic Checks

OESX does not have a ROIC to compare to the WACC, probably because it is not profitable.
OESX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OESX has more shares outstanding
OESX has a worse debt/assets ratio than last year.
OESX Yearly Shares OutstandingOESX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
OESX Yearly Total Debt VS Total AssetsOESX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

OESX has an Altman-Z score of -1.57. This is a bad value and indicates that OESX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.57, OESX is not doing good in the industry: 63.04% of the companies in the same industry are doing better.
OESX has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as OESX would need 2.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.92, OESX belongs to the top of the industry, outperforming 80.43% of the companies in the same industry.
OESX has a Debt/Equity ratio of 0.75. This is a neutral value indicating OESX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.75, OESX is doing worse than 63.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 2.92
Altman-Z -1.57
ROIC/WACCN/A
WACC8.38%
OESX Yearly LT Debt VS Equity VS FCFOESX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

OESX has a Current Ratio of 1.23. This is a normal value and indicates that OESX is financially healthy and should not expect problems in meeting its short term obligations.
OESX's Current ratio of 1.23 is on the low side compared to the rest of the industry. OESX is outperformed by 66.30% of its industry peers.
OESX has a Quick Ratio of 1.23. This is a bad value and indicates that OESX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, OESX is not doing good in the industry: 61.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.84
OESX Yearly Current Assets VS Current LiabilitesOESX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The earnings per share for OESX have decreased strongly by -366.67% in the last year.
OESX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.52%.
OESX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.97% yearly.
EPS 1Y (TTM)-366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-14.52%
Revenue growth 3Y-13.79%
Revenue growth 5Y-11.97%
Sales Q2Q%-1.66%

3.2 Future

Based on estimates for the next years, OESX will show a very strong growth in Earnings Per Share. The EPS will grow by 27.60% on average per year.
The Revenue is expected to grow by 12.03% on average over the next years. This is quite good.
EPS Next Y80.12%
EPS Next 2Y38.95%
EPS Next 3Y27.78%
EPS Next 5Y27.6%
Revenue Next Year4.12%
Revenue Next 2Y8.71%
Revenue Next 3Y11.5%
Revenue Next 5Y12.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OESX Yearly Revenue VS EstimatesOESX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
OESX Yearly EPS VS EstimatesOESX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OESX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OESX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OESX Price Earnings VS Forward Price EarningsOESX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OESX is valued cheaply inside the industry as 96.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.85
EV/EBITDA N/A
OESX Per share dataOESX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as OESX's earnings are expected to grow with 27.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.95%
EPS Next 3Y27.78%

0

5. Dividend

5.1 Amount

OESX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORION ENERGY SYSTEMS INC

NASDAQ:OESX (9/12/2025, 10:48:36 AM)

8.9731

+0.13 (+1.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners42.36%
Inst Owner Change-2.3%
Ins Owners7.51%
Ins Owner Change5.58%
Market Cap31.59M
Analysts84.44
Price Target12.53 (39.64%)
Short Float %N/A
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.03%
Min EPS beat(2)-65.45%
Max EPS beat(2)65.4%
EPS beat(4)2
Avg EPS beat(4)-11.29%
Min EPS beat(4)-65.45%
Max EPS beat(4)65.4%
EPS beat(8)4
Avg EPS beat(8)12.96%
EPS beat(12)4
Avg EPS beat(12)-97.66%
EPS beat(16)5
Avg EPS beat(16)-179.73%
Revenue beat(2)0
Avg Revenue beat(2)-3.32%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)-3.23%
Revenue beat(4)0
Avg Revenue beat(4)-12.64%
Min Revenue beat(4)-29.58%
Max Revenue beat(4)-3.23%
Revenue beat(8)1
Avg Revenue beat(8)-9.44%
Revenue beat(12)2
Avg Revenue beat(12)-9.26%
Revenue beat(16)2
Avg Revenue beat(16)-10.86%
PT rev (1m)570.01%
PT rev (3m)372.44%
EPS NQ rev (1m)-900%
EPS NQ rev (3m)-1677.78%
EPS NY rev (1m)8%
EPS NY rev (3m)-40.82%
Revenue NQ rev (1m)-2.09%
Revenue NQ rev (3m)-8.24%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-11.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF 10.85
P/OCF 10.37
P/B 2.92
P/tB 5.11
EV/EBITDA N/A
EPS(TTM)-1.26
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.83
FCFY9.21%
OCF(TTM)0.87
OCFY9.64%
SpS22.55
BVpS3.07
TBVpS1.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.95%
ROE -85.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.88%
FCFM 3.67%
ROA(3y)-29.62%
ROA(5y)-10.74%
ROE(3y)-84.8%
ROE(5y)-40.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.59%
GM growth 5Y0.98%
F-Score5
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 2.92
Debt/EBITDA N/A
Cap/Depr 5.91%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.84
Altman-Z -1.57
F-Score5
WACC8.38%
ROIC/WACCN/A
Cap/Depr(3y)22.53%
Cap/Depr(5y)33.15%
Cap/Sales(3y)0.61%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y80.12%
EPS Next 2Y38.95%
EPS Next 3Y27.78%
EPS Next 5Y27.6%
Revenue 1Y (TTM)-14.52%
Revenue growth 3Y-13.79%
Revenue growth 5Y-11.97%
Sales Q2Q%-1.66%
Revenue Next Year4.12%
Revenue Next 2Y8.71%
Revenue Next 3Y11.5%
Revenue Next 5Y12.03%
EBIT growth 1Y-9.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y152.15%
FCF growth 3YN/A
FCF growth 5Y-52%
OCF growth 1Y166.07%
OCF growth 3YN/A
OCF growth 5Y-50.59%